Nissan Medical Industries Cash Flow Statement

Financials in millions ILS. Fiscal year is January - December.

Millions ILS. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	4.17	7.91	5.65	-36.05	36.01
Depreciation & Amortization	27.8	29.64	31.14	28.65	25.6
Loss (Gain) From Sale of Assets	-	-	0.2	-0.04	0.07
Asset Writedown & Restructuring Costs	-	-	-	23.79	-
Loss (Gain) From Sale of Investments	-0.13	-0.01	-0.01	0.05	-5.39
Loss (Gain) on Equity Investments	-0.18	-1.3	7.06	0.64	-4.62
Stock-Based Compensation	0.47	1.18	0.58	0.27	1.45
Other Operating Activities	15.17	17.07	34.08	3.61	25.89
Change in Accounts Receivable	-8.48	20.61	33.8	-19.71	-16.45
Change in Inventory	42.41	-54.41	-6.07	8.41	-52
Change in Accounts Payable	-19.04	7.08	-7.41	5.29	12.21
Change in Other Net Operating Assets	0.45	-0.94	6.69	-3.22	-4.8
Operating Cash Flow	62.64	26.83	105.72	11.67	17.98
Operating Cash Flow Growth	133.44%	-74.62%	805.56%	-35.07%	-85.33%
Capital Expenditures	-26.11	-6.09	-9.82	-9.18	-8.16
Sale of Property, Plant & Equipment	0.06	0.03	0.26	0.17	0.03
Sale (Purchase) of Intangibles	-0.02	-0.21	-0.36	-0.51	-0.14
Investment in Securities	1.7	13.79	-	-0.15	8.42
Other Investing Activities	10.66	-11.39	-	-	5.48
Investing Cash Flow	-13.71	-3.87	-9.93	-9.68	5.62
Short-Term Debt Issued	10.25	23.92	7.32	13.37	-
Long-Term Debt Issued	55.72	49.11	-	42.71	89.91
Total Debt Issued	65.97	73.03	7.32	56.08	89.91
Short-Term Debt Repaid	-	-0.5	-	-	-3.42
Long-Term Debt Repaid	-81.84	-74.91	-73.67	-66.82	-80.87
Total Debt Repaid	-81.84	-75.41	-73.67	-66.82	-84.29
Net Debt Issued (Repaid)	-15.87	-2.38	-66.35	-10.75	5.61
Common Dividends Paid	-16.53	-6.81	-	-4	-9.08
Other Financing Activities	-12.32	-23.18	-24.36	-11.04	-27.73
Financing Cash Flow	-44.72	-32.37	-90.71	-25.78	-31.2
Foreign Exchange Rate Adjustments	-2.23	0.26	0.46	3.03	-0.88
Net Cash Flow	1.99	-9.14	5.53	-20.75	-8.48
Free Cash Flow	36.53	20.74	95.9	2.49	9.82
Free Cash Flow Growth	76.09%	-78.37%	3745.07%	-74.60%	-90.97%
Free Cash Flow Margin	5.60%	3.12%	13.07%	0.36%	1.47%
Free Cash Flow Per Share	4.02	2.28	10.56	0.28	1.08
Cash Interest Paid	12.32	13.79	16.31	11.04	10.11
Cash Income Tax Paid	2.99	6.29	9.3	2.34	11.64
Levered Free Cash Flow	45.74	5.89	54.04	-4.51	-1.37
Unlevered Free Cash Flow	53.24	14.23	67.33	1.75	3.18
Change in Working Capital	15.33	-27.65	27.02	-9.24	-61.03

Source: S&P Global Market Intelligence. Standard template. Financial Sources.